Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Eyenovia

12.29.20

Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi

Source: Eyenovia

12.16.20

Eyenovia Announces First Patients Enrolled in Phase 3 Study of MicroLine for Presbyopia

Source: Eyenovia

12.03.20

FDA Approves Eyenovia’s IND Application for MicroLine for Presbyopia, Allowing for Phase 3 Trials

Source: Eyenovia

10.12.20

Bausch Health Licenses Eyenovia’s Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12

Source: Bausch Health

10.08.20

Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meeting

Source: Eyenovia

08.11.20

Eyenovia and Arctic Vision Announce License Agreement to Develop and Commercialize Products in Greater China and South Korea

Source: Eyenovia

10.29.19

Eyenovia Advances MicroLine for the Treatment of Presbyopia; Reprioritizes Late-Stage Ophthalmology Pipeline

Source: Eyenovia

06.05.19

Eyenovia Enrolls First Patient in Phase 3 CHAPERONE Study for Progressive Myopia

Source: Eyenovia

05.06.19

Eyenovia Announces Presentation of Successful Phase 3 Studies at the ASCRS

Source: Eyenovia

02.25.19

Eyenovia Announces Confirmatory Results from Second MicroStat Phase 3 Registration Study for Mydriasis

Source: Eyenovia

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.